{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:36:12Z","timestamp":1783096572314,"version":"3.54.6"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>The oral bioavailability of cyclosporine, a substrate of both CYP3A4 and P\u2010glycoprotein, is subject to large inter\u2010individual variability, which requires frequent monitoring of plasma concentrations. In 1997, the study by Lown <jats:italic>et\u00a0al<\/jats:italic>. showed that\u2014in addition to hepatic CYP3A4\u2014the expression of P\u2010gp in the intestine significantly influences the pharmacokinetics of cyclosporine in kidney transplant patients. The results contributed considerably to a better understanding of the function of the intestinal P\u2010glycoprotein for drug clearance.<\/jats:p>","DOI":"10.1002\/cpt.3619","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:38:55Z","timestamp":1747665535000},"page":"1546-1561","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Deciphering the Relative Contribution of <scp>CYP3A4<\/scp> Versus P\u2010Glycoprotein for the Shared Substrate Cyclosporine\u2014Commentary on Lown <i>et al<\/i>."],"prefix":"10.1002","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2182-9534","authenticated-orcid":false,"given":"Ingolf","family":"Cascorbi","sequence":"first","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology University Hospital Schleswig\u2010Holstein  Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-1632","authenticated-orcid":false,"given":"Richard B.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology Western University  London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"e_1_2_5_1_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00877-1"},{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-14541-4_6"},{"key":"e_1_2_5_3_1","first-page":"213","article-title":"Multidrug resistance mediated by P\u2010glycoproteins","volume":"2","author":"Schinkel A.H.","year":"1991","journal-title":"Semin. Cancer Biol."},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.21.7735"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90212-7"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)08713-9"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)12089-2"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90601-7"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)22834-8"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90027-8"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6663"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12055"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018877803319"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1991.tb03603.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01759.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.7.3473"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31820feb8e"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100882"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318169c380"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.1876661"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.3619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T17:17:51Z","timestamp":1748193471000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.3619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/cpt.3619"],"URL":"https:\/\/doi.org\/10.1002\/cpt.3619","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"2025-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}